📰 Merck Sharp News
Page 84 - Merck Sharp News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Merck Sharp. Real-time updates on events, politics, business and more.
January 20, 2022
Australia's Therapeutic Goods Administration (TGA) has this week approved the Novavax vaccine and two oral COVID treatments to reduce the chance of severe disease.
January 20, 2022
Australians at a high risk of developing severe COVID illness will be given access to two potentially lifesaving treatments.
January 20, 2022
This is Business Insider Australia's morning newsletter for Thursday, January 20.
January 20, 2022
Australia has secured 800,000 doses of COVID-19 antiviral pills. Here's what we know so far about molnupiravir and nirmatrelvir + ritonavir.
January 20, 2022
Novavax vaccine, oral COVID-19 treatments approved in Australia-
January 19, 2022
Influenza Vaccine Market is Registering at a CAGR of 7.20% from 2021 to 2030 | Current Trends and Growth Opportunity
January 19, 2022
Influenza Vaccine Market is Registering at a CAGR of 7.20% from 2021 to 2030 | Current Trends and Growth Opportunity
January 19, 2022
The Therapeutic Goods Administration (TGA) has granted provisional approval to two oral COVID-19 treatments: PAXLOVID (nirmatrelvir + ritonavir) –
January 18, 2022
/PRNewswire/ -- Allied Market Research recently published a report, titled, "Liver Disease Treatment Market by Treatment Type (Antiviral Drugs,...